Immediate Impact

1 from Science/Nature 45 standout
Sub-graph 1 of 21

Citing Papers

Plant-mediated green synthesis of silver nanoparticles: Synthesis, characterization, biological applications, and toxicological considerations: A review
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
3 intermediate papers

Works of Con Dolianitis being referenced

Tildrakizumab in the treatment of moderate‐to‐severe hidradenitis suppurativa
2020
Optimal treatment of head lice: is a no-nit policy justified?1 1Edited By Stephen P. Stone
2002

Author Peers

Author Last Decade Papers Cites
Con Dolianitis 83 62 61 95 17 242
William G. Stebbins 113 30 69 65 19 282
Jónas A. Aðalsteinsson 180 56 115 46 30 294
S. Guillet 50 62 42 92 16 271
Hugh Roberts 172 21 50 75 17 289
A. Daponte 26 63 86 50 13 291
Yuval Ramot 81 63 31 15 27 285
Zakiya P. Rice 144 25 16 36 15 255
Enes Hajdarbegovic 119 158 24 35 17 297
S. Pérez‐Gala 104 88 72 28 23 266
Piotr Ciechanowicz 103 90 61 31 22 261

All Works

Loading papers...

Rankless by CCL
2026